- Home
- ZUMZ vs CDXS Comparison
ZUMZ vs CDXS Comparison
Compare ZUMZ & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- CDXS
- Stock Information
- Founded
- ZUMZ 1978
- CDXS 2002
- Country
- ZUMZ United States
- CDXS United States
- Employees
- ZUMZ N/A
- CDXS N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- CDXS Major Chemicals
- Sector
- ZUMZ Consumer Discretionary
- CDXS Industrials
- Exchange
- ZUMZ Nasdaq
- CDXS Nasdaq
- Market Cap
- ZUMZ 401.1M
- CDXS 332.0M
- IPO Year
- ZUMZ 2005
- CDXS 2010
- Fundamental
- Price
- ZUMZ $20.52
- CDXS $5.61
- Analyst Decision
- ZUMZ Hold
- CDXS Buy
- Analyst Count
- ZUMZ 2
- CDXS 2
- Target Price
- ZUMZ $22.00
- CDXS $11.00
- AVG Volume (30 Days)
- ZUMZ 306.3K
- CDXS 691.3K
- Earning Date
- ZUMZ 12-05-2024
- CDXS 10-31-2024
- Dividend Yield
- ZUMZ N/A
- CDXS N/A
- EPS Growth
- ZUMZ N/A
- CDXS N/A
- EPS
- ZUMZ N/A
- CDXS N/A
- Revenue
- ZUMZ $891,864,000.00
- CDXS $64,446,000.00
- Revenue This Year
- ZUMZ $4.32
- CDXS N/A
- Revenue Next Year
- ZUMZ $2.19
- CDXS $2.02
- P/E Ratio
- ZUMZ N/A
- CDXS N/A
- Revenue Growth
- ZUMZ 2.07
- CDXS N/A
- 52 Week Low
- ZUMZ $12.90
- CDXS $2.53
- 52 Week High
- ZUMZ $31.37
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- ZUMZ 43.75
- CDXS 71.90
- Support Level
- ZUMZ $19.47
- CDXS $5.42
- Resistance Level
- ZUMZ $22.22
- CDXS $6.01
- Average True Range (ATR)
- ZUMZ 1.35
- CDXS 0.33
- MACD
- ZUMZ -0.24
- CDXS 0.03
- Stochastic Oscillator
- ZUMZ 23.63
- CDXS 69.68
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.